Roche Holding AG
http://www.roche.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Roche Holding AG
Five Late-Breaking Studies To Look Out For At ASCO
Ahead of the American Society of Clinical Oncology meeting in early June, analysts at Biomedtracker have highlighted select high-impact late-breaking abstracts that are due to presented, including therapies from AbbVie, Gilead Sciences, Pfizer, Takeda, Amgen, AstraZeneca and Daiichi Sankyo.
Can Roche’s Phesgo Mirror UK Adoption Trend in India?
Roche debuts ‘responsibly priced’ Phesgo in India. Will the dramatic reduction in treatment time for women with HER2 positive breast cancer and other benefits, including insurance coverage, trigger sharp shifts towards the subcutaneous fixed-dose combination of Perjeta and Herceptin?
Bristol’s Opdivo Stumbles On Its Way To First-Line Bladder Cancer Indication
The CheckMate-901 trial failed on one of its primary endpoints, but the company will continue the trial to explore additional primary endpoints.
Boehringer Bids To Go Beyond Slowing IPF
The family-owned German group is the market leader in idiopathic pulmonary fibrosis with Ofev but the big-selling drug has significant side effects and only slows, but does not stop, the progression of the disease. It is hoping that the Phase III-ready compound BI 1015550 will offer a significant improvement.
Company Information
- Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
-
- Adheron Therapeutics
- Anadys Pharmaceuticals, Inc.
- Ariosa Diagnostics
- Arius Research, Inc.
- Boehringer Mannheim
- CAPP Medical
- Chugai Pharmaceutical Co., Ltd.
- Dutalys GmbH
- Flatiron Health
- Foundation Medicine
- GenMark Diagnostics, Inc.
- Genentech Inc.
- GeneWEAVE BioSciences, Inc.
- Genia Technologies, Inc.
- GlycArt Biotechnology
- Hoffmann-La Roche
- Inflazome Ltd.
- Ignyta, Inc. (RXDX) (Actagene Oncology, Inc
- NexDx, Inc.)
- Inception 5
- InterMune, Inc.
- Inflazome Ltd.
- IQuum, Inc.
- Jecure Therapeutics
- Kapa Biosystems, Inc.
- Marcadia Biotech, Inc.
- Medingo Ltd.
- Memory Pharmaceuticals Corporation
- mtm laboratories AG
- Piramed Pharma
- Santaris Pharma A/S
- Seragon Pharmaceuticals
- Signature Diagnostics AG
- Stratos Genomics
- Syntex Corporation
- Tanox, Inc.
- Tensha Therapeutics, Trophos SA
- Ventana Medical Systems, Inc.
- Viewics, Inc.